Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
OncoZenge said its rights issue concluded at approximately 92% subscription.Material DetailsContext by AI AnalystThis is a financing update, reinforcing the company's ability to raise capital but with a small shortfall. A larger catalyst would require details on proceeds, allocation of any unsubscr…
OncoZenge AB (publ) said its rights issue was approx. 92% subscribed, raising gross proceeds of about SEK 30.7M at SEK 3.00 per share, with no use of the guarantee.
OncoZenge AB's preliminary rights issue results indicate that approximately 92% of shares were subscribed for, with expected gross proceeds of SEK 30.7 million before costs. The subscription guarantee commitment from Vator Securities Ab is not expected to be utilized.
OncoZenge’s rights issue is preliminarily ~92% subscribed: 80% with rights and 12% without. Expected gross proceeds are ~SEK 30.7M, and the Vator Securities AB guarantee is not expected to be utilised.